Inovio to Lay Off 18% of Staff after COVID Shot Struggles

Inovio to Lay Off 18% of Staff after COVID Shot Struggles

Inovio said Tuesday it will cut 18% of its workforce and 86% of its contractors as the company looks to reduce expenses after high-profile challenges in its efforts to produce a COVID-19 vaccine. CEO Jacqueline Shea said the reorganization will help Inovio focus on its lead programs, which include the COVID-19 vaccine and a medicine to treat HPV-associated precancerous cervical dysplasia. Inovio’s share price soared in the spring and summer of 2020 as the company leaped into development of a coronavirus vaccine.

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 29, 2024 at 11:21am